Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells

Glioblastoma Multiforme (GBM) is a highly prevalent and deadly brain malignancy characterized by poor prognosis and restricted disease management potential. Despite the success of nanocarrier systems to improve drug/gene therapy for cancer, active targeting specificity remains a major hurdle for GBM...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayward, Stephen L., Wilson, Christina L., Kidambi, Srivatsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085145/
https://www.ncbi.nlm.nih.gov/pubmed/27120809
http://dx.doi.org/10.18632/oncotarget.8926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085145/
https://www.ncbi.nlm.nih.gov/pubmed/27120809
http://dx.doi.org/10.18632/oncotarget.8926

Ejemplares similares